3DIGNAM J D,RUSSELL M L,ROEDER R G.Accurate transcription initiation by RNA polymerase Ⅱ in a soluble extract from isolated mammalian nucle[J].Nucleic Acids Res,1993,12(5):1475-1489.
4YUN H Y,DAWSON V L,DAWSON T M.Neurobiology of nitric oxide[J].Crit Rev Neurobiol,1996,10:291-316.
5LADECOLA C,ZHANG F,CUSEY R,et el.Knockout mice lacking the inducible nitric oxide synthase gene are resistant to ceerebral ischemia[J].Soc Neurosic,1996,18:609-620.
6HEFER R E,CHRISTOPHERSON T J,SCHEITHAUER B W,et al.The effect of platelet activating factor antagonist (BN 5202) on neurologic outcome and histopathology in a canine model of complete cerebral ischemia[J].J Clin Pharmacol,1993,79 (2):347-353.
7LIU X H,KATO H,ARAKI T,et el.An immunohistochemical study of copper/zinc superoxide dismutase and manganese superoxide dismutase following focal cerebral ischemia in the rat[J].Brain Res,1994,644:257-266.
8DIGNAM J D, RUSSELL M L, ROEDER R G. Accurate transcription initiation by RNA polymerase Ⅱ in a soluble extract from isolated mammalian nuclei [ J ]. Nucleic Acids Res, 1993,12(5) :1475 - 1489.
9YUN H Y, DAWSON V L, DAWSON T M. Neurobiology of nitric oxide[JJ. Crit Rev Neurobiol, 1996, 10(3 - 4) :291 -316.
10HEFER R E, CHRISTOPHERSON T J, SCHEITHAUER B W, et al. The effect of platelet activating factor antagonist ( BN 5202) on neurologic outcome and histopathology in a canine model of complete cerebral ischemia [ J ]. J Clin Pharmacol, 1993,79(2) :347 -353.
